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New diagnostics for pulmonary tuberculosis in
children
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Accurate diagnosis of childhood pulmonary tuberculosis (PTB)
has become increasingly important to deﬁne the burden of child-
hood TB, initiate appropriate therapy early and treat drug resistant
disease effectively. Clinical scoring systems, radiological ﬁndings
and tuberculin skin testing, traditional methods for diagnosis, are
unreliable especially in the era of HIV. There have been several
recent advances in strategies to strengthen microbiologic diagno-
sis in children. Improved specimen collection, particularly the use
of sputum induction to obtain a reliable specimen for microbio-
logic testing, has been found to be feasible and effective even in
infants. In hospitalized children, a single induced sputum provides
a similar culture yield to 3 gastric lavages. Sputum induction, done
as an ambulatory procedure in primary care settings, is effective,
increasing the diagnostic yield for PTB substantially in children. The
culture yield from nasopharyngeal specimens (NPs) is lower than
that from induced sputum or from gastric lavage.
The development of XpertMTB/RIF is an important advance that
has enabled rapid diagnosis and simultaneous detection of resis-
tance to rifampicin. Xpert testing of 2 induced sputum specimens
detect approximately 75% of children with culture conﬁrmed dis-
ease, almost 3 fold that of smear. Xpert on 2 sequential NPs may
also be useful for microbiologic conﬁrmation in hospitalised chil-
dren. The World Health Organisation has recommended that Xpert
replace smear as the ﬁrst line investigation in children living in
areasofhighHIVprevalenceorwheredrug resistant TB is a concern.
Urine lipoarabinomannan is not useful for diagnosis in children,
including those who are HIV-infected or severely immunocompro-
mised.
Greater efforts are needed to ensure the strengthening of capac-
ity to enable microbiologic diagnosis in children including more
widespread use of sputum induction and access to Xpert. Further
research is needed to develop a rapid point of care, reliable and
affordable diagnostic test for TB that can bewidely used in children
with suspected PTB.
http://dx.doi.org/10.1016/j.ijid.2014.03.533
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The 2011 World Health Organization Consensus Guidelines for
IPT for adults recommended that adults and adolescents living
with HIV (with an unknown or +TST and without active TB) should
receive daily isoniazid(INH) for at least 6 months. The 2011 WHO
guidelines for IPT in HIV infected-children similarly recommended
6 months of IPT(10mg/Kg/day) for HIV –infected children but only
for those over 12 months of age. For those less than 12 months,
IPT was recommended only for those without TB disease who have
had contactwith a TB case.While the adult recommendationswere
based upon 12 studies involving over 8500 randomized patients;
the pediatric recommendations were based only upon 2 (Zar et al,
BMJ, 2007 and Madhi et al, NEJM, 2011). Both were prospective,
double blind, placebo controlled studies designed to determine the
efﬁcacy of IPT in HIV infected children in southern Africa. The Zar
study found that both the incidence of TB andmortalitywere lower
in the INHgroupwith thedifference inmortalitybeingnotedwithin
the ﬁrst months post randomization. There was no such beneﬁt in
either of these parameters in the Madhi study. The apparent dis-
crepancy in the outcomes of these 2 studies may be the result of
differences in the timing of the respective studies relative to the
roll-out of HAART and the resulting percentage of children in each
study onHAART, the respective stages of HIV disease at enrollment,
differences in the age groups targeted for enrollment, and prior his-
tory of TB exposure and/or disease. Previous observational data has
suggested that ∼40-60% of children primarily infected with TB at
less than 12months of age develop primary TB disease(30-40% pul-
monary disease; 10-20%miliary disease or TBmeningitis)while the
majority of children over 12-24months develop latent TB infection
following primary infection(only 5-15% develop primary TB dis-
ease). A comparisonof the results fromthese2 studies suggests that
while IPT is effective among HIV infected children over 12 months
who likely have latent TB infection (secondary prophylaxis); IPT
is not effective as primary prophylaxis for preventing primary TB
infection.
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